The Research and Development team at Mitobridge is dedicated to pioneering innovative small molecule modulators aimed at enhancing mitochondrial function. Comprising a diverse group of scientists and researchers, the team conducts cutting-edge studies, develops experimental designs, and drives translational science efforts to identify biomarkers, ultimately translating their findings into effective therapeutic solutions for mitochondrial-related diseases.
Andrew Dillin
Scientific Founder
Grace Nauman
Scientist II
Jeff Stanwix
Senior Research Associate
Johan Auwerx
Scientific Founder
Leslie
Principle Scientist
Peter Dwyer
Scientist, Translational Biolo...
Robert Horvitz
Scientific Founder
Ron Evans
Scientific Founder
Sabina Spofford
Research Associate II
Sowmya Balasubramani...
Senior Scientist (translationa...
View all